Cargando…

Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity

INTRODUCTION: Systemic lupus erythematosus (SLE) is characterized by impaired efferocytosis and aberrant activation of innate immunity. We asked if shedding of MER receptor tyrosine kinase (MerTK) and AXL into soluble (s) ectodomains was related to immunological and clinical aspects of SLE. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zizzo, Gaetano, Guerrieri, Justus, Dittman, Lindsay M, Merrill, Joan T, Cohen, Philip L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978923/ https://www.ncbi.nlm.nih.gov/pubmed/24325951 http://dx.doi.org/10.1186/ar4407

Ejemplares similares

Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy
por: Hilliard, Brendan A, et al.
Publicado: (2014)

TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
por: Suh, Chang-Hee, et al.
Publicado: (2010)

Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins
por: Zizzo, Gaetano, et al.
Publicado: (2023)

Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
por: Wu, Jun, et al.
Publicado: (2011)

Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies
por: Bagavant, Harini, et al.
Publicado: (2021)

The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarization
por: Zizzo, Gaetano, et al.
Publicado: (2015)

Autoantibodies targeting to GPER1 promote monocyte cytokines production and inflammation in systemic lupus erythematosus
por: Zhang, Xinwei, et al.
Publicado: (2023)

Lots of autoantibodies equal lupus?
por: Aringer, Martin, et al.
Publicado: (2013)

Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls
por: Knudsen, Andreas D., et al.
Publicado: (2022)

Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity
por: Askanase, Anca D., et al.
Publicado: (2019)

Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals
por: Park, Juwon, et al.
Publicado: (2023)

Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE)
por: Jiang, Wei, et al.
Publicado: (2014)

Detection by Flow Cytometry of Anti-DNA Autoantibodies and Circulating DNA Immune Complexes in Lupus Erythematosus
por: Abuaf, Nisen, et al.
Publicado: (2019)

Protective natural autoantibodies and lupus pathogenesis
por: Silverman, Gregg J
Publicado: (2014)

The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy
por: Moroni, Gabriella, et al.
Publicado: (2015)

Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
por: Pan, Qingjun, et al.
Publicado: (2017)

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity
por: Thornhill, Susannah I., et al.
Publicado: (2017)

Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?
por: Thanou, A, et al.
Publicado: (2012)

Lupus autoantibodies target ribosomal P proteins
Publicado: (1985)

Autoantibodies and cognitive impairment in systemic lupus erythematosus
por: Kowal, C, et al.
Publicado: (2004)

Do we need new autoantibodies in lupus?
por: Scofield, R Hal
Publicado: (2010)

Autoantibody profiling to follow evolution of lupus syndromes
por: Olsen, Nancy J, et al.
Publicado: (2012)

Mechanisms of Autoantibody Production in Systemic Lupus Erythematosus
por: Han, Shuhong, et al.
Publicado: (2015)

Autoantibody clustering of lupus-associated pulmonary hypertension
por: Mizus, Marisa, et al.
Publicado: (2019)

Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
por: Howe, Hwee Siew, et al.
Publicado: (2019)

Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis
por: Dieker, Jürgen, et al.
Publicado: (2016)

Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus
por: Sun, Jingjing, et al.
Publicado: (2019)

Commentary: Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
por: Poddighe, Dimitri, et al.
Publicado: (2017)

Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus
por: Hartl, Johannes, et al.
Publicado: (2021)

ELEVATED CIRCULATING MONOCYTES AND MONOCYTE ACTIVATION IN PULMONARY POSTACUTE SEQUELAE OF SARS-COV-2 INFECTION
por: PARK, JUWON, et al.
Publicado: (2022)

Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus
por: Ballantine, Lucy, et al.
Publicado: (2015)

Impact of heart rate variability, a marker for cardiac health, on lupus disease activity
por: Thanou, Aikaterini, et al.
Publicado: (2016)

Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus
por: Haddon, D. James, et al.
Publicado: (2015)

Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus
por: Plawecki, Maëlle, et al.
Publicado: (2016)

Idiotypic cross-reactions of monoclonal human lupus autoantibodies
Publicado: (1983)

Two Major Autoantibody Clusters in Systemic Lupus Erythematosus
por: Ching, Kathryn H., et al.
Publicado: (2012)

Maintenance of autoantibody production in pristane-induced murine lupus
por: Han, Shuhong, et al.
Publicado: (2015)

The Association between Autoantibodies and Peripheral Neuropathy in Lupus Nephritis
por: Su, Yu-Jih, et al.
Publicado: (2014)

Cytokine and autoantibody clusters interaction in systemic lupus erythematosus
por: Pacheco, Yovana, et al.
Publicado: (2017)

Peroxidasin Is a Novel Target of Autoantibodies in Lupus Nephritis
por: Manral, Pallavi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jhnubu3p9icomc0phm0i9dh80l